Home > Boards > US Listed > Alternative Energy > Adventure Gold Inc. (AGE)

AGE Looking for Partners

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
bobby2loaves Member Profile
 
Followed By 0
Posts 69
Boards Moderated 0
Alias Born 03/31/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2019 4:13:40 PM
AgeX Therapeutics to Present at Metabesity 2019 Business Wire - 10/11/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:30:55 AM
Industry Leaders Aubrey De Grey And Frank Jaksch Join Yuva Biosciences Advisory Board PR Newswire (US) - 9/10/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 7:01:12 AM
AgeX Therapeutics Presents at the Rodman & Renshaw Global Investment Conference Business Wire - 9/9/2019 7:00:00 AM
AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine Business Wire - 9/4/2019 8:00:00 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 8/16/2019 4:02:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 2:51:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 5:30:34 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 5:17:09 PM
AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire - 8/14/2019 5:16:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 5:17:45 PM
Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors Business Wire - 8/5/2019 5:14:00 PM
AgeX Therapeutics’ CEO Dr. Michael D. West to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Re... Business Wire - 7/9/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:54:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 4:44:52 PM
AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire - 5/15/2019 4:05:00 PM
AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health and Foresight Institute Business Wire - 5/1/2019 8:00:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 4:47:46 PM
AgeX Therapeutics to Present at Master Investor Show 2019 Business Wire - 4/5/2019 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 5:24:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2019 5:05:13 PM
AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update Business Wire - 4/1/2019 4:48:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2019 4:58:49 PM
bobby2loaves   Friday, 02/01/19 07:13:01 AM
Re: None
Post # of 44 
AGE Looking for Partners

For the past 2 months, AGE has been ending its press releases with the following sentence. I think this is why they haven't tried to drum up capital with share offerings, or through the spinoff: "AgeX is aggressively developing its core product pipeline for use in the clinic to extend human healthspan, and is seeking opportunities to form licensing and partnership agreements around its broad IP estate and proprietary technology platforms for non-core clinical applications."

I think this may be one of the benefits of having Juvenescence with a 40%+ stake in the company. They might rather sell off small pieces of the company's short-term projects (at a premium) than dilute the entire company (with the market forcing the share price down in anticipation of share placements) and preserve the holy grail of iTR undiluted. It's not been Mike West's style lately to play like this, but if I am guessing right about what's happening here, I think it's genius.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist